We are live on
!
Find out more
Galectin Therapeutics
GALT
GALT
75 hedge funds and large institutions have $25.3M invested in Galectin Therapeutics in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
144% more call options, than puts
Call options by funds: $1.8M | Put options by funds: $737K
12% more capital invested
Capital invested by funds: $22.7M → $25.3M (+$2.64M)
0% more funds holding
Funds holding: 75 → 75 (0)
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
3.78% less ownership
Funds ownership: 17.41% → 13.62% (-3.8%)
35% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 20
Holders
75
Holders Change
–
Holders Change %
0%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
13
Reduced
20
Closed
20
Calls
$1.8M
Puts
$737K
Net Calls
+$1.06M
Net Calls Change
+$1.1M
Top Buyers
| 1 |
Millennium Management
New York
|
+$2.02M |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$599K |
| 3 |
E
Ergoteles
New York
|
+$495K |
| 4 |
HF
HRT Financial
New York
|
+$373K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$351K |
Top Sellers
| 1 |
BlackRock
New York
|
-$6.5M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.62M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$1.16M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$843K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$384K |
